Pharmacokinetics and metabolic effects of high-dose growth hormone administration in healthy adult men

被引:5
作者
Tanaka, T
Seino, Y
Fujieda, K
Igarashi, Y
Yokoya, S
Tachibana, K
Ogawa, Y
机构
[1] Natl Childrens Med Res Ctr, Dept Endocrinol & Metab, Setagaya Ku, Tokyo 1548509, Japan
[2] Okayama Univ, Dept Pediat, Okayama 7000914, Japan
[3] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido 0600814, Japan
[4] Igarashi Pediat Clin, Sendai, Miyagi 9813203, Japan
[5] Toranomon Gen Hosp, Dept Pediat, Tokyo 1050001, Japan
[6] Kanagawa Childrens Med Ctr, Div Endocrinol & Metab, Yokohama, Kanagawa 2320066, Japan
[7] Saitama Med Ctr, Dept Pediat, Kawagoe, Saitama 3500844, Japan
关键词
high-dose GH; insulin; triglyceride; healthy adult;
D O I
10.1507/endocrj.46.605
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate pharmacokinetics of growth hormone (GH) and its effects on IGF-I, glucose, insulin, nonesterified fatty acid (NEFA) and triglyceride (TG), fifteen Japanese healthy adult male volunteers (20-27 years old) were studied. The subjects were divided into three groups, and received with a single s.c. injection of 0.075, 0.15 and 0.30 IU/kg of GK, respectively. The subjects assigned to receive 0.30 IU/kg were administered for additional 6 days. After a single administration of GH, Cmax and AUC of GH were increased in a dose-dependent manner. There was a significant positive correlation between the AUC and the T1/2 (r=0.516, P<0.05). Total body clearance was significantly greater in 0.075 IU/kg group than the other groups and showed a significant negative correlation with Cmax (r=-0.694, P<0.005) and AUC (r=-0.723, P<0.005). After a single administration of each dose, serum IGF-I concentrations were increased gradually. In the repeated administered group (0.30 IU/kg), IGF-I concentrations almost reached a plateau at a significantly high level four days after the start of administration and remained at a high level (786-405.4 ng/ml) until day 8. There was no significant difference in diurnal change of blood glucose and serum insulin after a single administration of GH among three groups. In the 0.3 U/kg group, there was no significant difference in diurnal change of blood glucose between day 1 and day 7, but serum insulin level was significantly higher in day 7 than in day 1 (P<0.01). Serum concentrations of NEFA were increased over time after administration in all subjects administered once or repeatedly. TG concentrations showed no changes after single administration of each dose level, but were significantly increased on day 7 in the subjects repeatedly treated with 0.30 IU/kg/day. This effect is speculated to be caused by high dose GH treatment. The above findings demonstrated that higher GH dose significantly influences on carbohydrate and lipid metablism. It remains necessary to elucidate what kinds of effects of the long-lasting increased levels of insulin and triglyceride, even if reversible, would have on glucose and lipid metabolism.
引用
收藏
页码:605 / 612
页数:8
相关论文
共 20 条
[1]   THE EFFECTS OF SHORT AND LONG-TERM GROWTH-HORMONE REPLACEMENT THERAPY IN HYPOPITUITARY ADULTS ON LIPID-METABOLISM AND CARBOHYDRATE-TOLERANCE [J].
BESHYAH, SA ;
HENDERSON, A ;
NITHTHYANANTHAN, R ;
SKINNER, E ;
ANYAOKU, V ;
RICHMOND, W ;
SHARP, P ;
JOHNSTON, DG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02) :356-363
[2]   EFFECT OF GROWTH-HORMONE ON CARBOHYDRATE AND LIPID-METABOLISM [J].
DAVIDSON, MB .
ENDOCRINE REVIEWS, 1987, 8 (02) :115-131
[3]   High-dose growth hormone treatment of short children born small for gestational age [J].
deZegher, F ;
Maes, M ;
Gargosky, SE ;
Heinrichs, C ;
DuCaju, MVL ;
Thiry, G ;
DeSchepper, J ;
Craen, M ;
Breysem, L ;
Lofstrom, A ;
Jonsson, P ;
Bourguignon, JP ;
Malvaux, P ;
Rosenfeld, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1887-1892
[4]   STIMULATION OF INVITRO TRIGLYCERIDE SYNTHESIS IN THE RAT HEPATOCYTE BY GROWTH-HORMONE TREATMENT INVIVO [J].
ELAM, MB ;
SIMKEVICH, CP ;
SOLOMON, SS ;
WILCOX, HG ;
HEIMBERG, M .
ENDOCRINOLOGY, 1988, 122 (04) :1397-1402
[5]   DOSE-RESPONSE STUDIES WITH BIOSYNTHETIC HUMAN GROWTH-HORMONE (GH) IN GH-DEFICIENT PATIENTS [J].
JORGENSEN, JOL ;
FLYVBJERG, A ;
LAURITZEN, T ;
ALBERTI, KGMM ;
ORSKOV, H ;
CHRISTIANSEN, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :36-40
[6]   NEAR NORMALIZATION OF ADOLESCENT HEIGHT WITH GROWTH-HORMONE THERAPY IN VERY SHORT CHILDREN WITHOUT GROWTH-HORMONE DEFICIENCY [J].
LESAGE, C ;
WALKER, J ;
LANDIER, F ;
CHATELAIN, P ;
CHAUSSAIN, JL ;
BOUGNERES, PF .
JOURNAL OF PEDIATRICS, 1991, 119 (01) :29-34
[7]   CARBOHYDRATE-TOLERANCE AND INSULIN RECEPTOR-BINDING IN CHILDREN WITH HYPOPITUITARISM - RESPONSES AFTER ACUTE AND CHRONIC HUMAN GROWTH-HORMONE ADMINISTRATION [J].
LIPPE, BM ;
KAPLAN, SA ;
GOLDEN, MP ;
HENDRICKS, SA ;
SCOTT, ML .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (03) :507-513
[8]   THE INVITRO EFFECT OF GROWTH-HORMONE ON ADIPOSE-TISSUE LIPOPROTEIN-LIPASE IN RATS [J].
MURASE, T ;
YAMADA, N ;
MATSUZAKI, F .
LIFE SCIENCES, 1981, 28 (02) :199-201
[9]   DECLINE OF POST-HEPARIN PLASMA-LIPOPROTEIN LIPASE IN ACROMEGALIC PATIENTS [J].
MURASE, T ;
YAMADA, N ;
OHSAWA, N ;
KOSAKA, K ;
MORITA, S ;
YOSHIDA, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1980, 29 (07) :666-672
[10]   ACROMEGALY [J].
NABARRO, JDN .
CLINICAL ENDOCRINOLOGY, 1987, 26 (04) :481-512